Osaic Holdings’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Osaic Holdings's NKTR Position: Q3 2026 in Review
Osaic Holdings increased its Nektar Therapeutics (NKTR) stake by 12% in Q3 2026, buying an estimated $36.1K and bringing the position to 4,697 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #4164.
Osaic Holdings first reported a position in NKTR in Q1 2020 and has held it in 27 quarters since. The position peaked at $3.46M in Q1 2022. 243 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.
- Osaic Holdings held 4,697 shares of Nektar Therapeutics worth $284K as of Q3 2026.
- Osaic Holdings bought 514 Nektar Therapeutics shares in Q3 2026, an estimated $36.1K.
- Nektar Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #4164 holding.
- Osaic Holdings first reported a position in Nektar Therapeutics in Q1 2020 and has held it in 27 quarters since.
- Osaic Holdings's Nektar Therapeutics position peaked at $3.46M in Q1 2022.
- 243 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.